1 hour, 28 minutes ago NEW YORK (Reuters) - A U.S. judge ruled in favor of shareholders suing Bristol-Myers Squibb (BMY.N) about its disclosures while settling patent litigation with Canadian generic drug maker Apotex Inc over the blood-thinner Plavix.Manhattan federal court Judge Paul Crotty wrote that the shareholders had "plausibly alleged that Bristol Myers' silence with regard to the details of the Apotex settlement made its public statements misleading or false."
Bristol-Myers said in an emailed statement on Wednesday that its efforts to settle with Apotex "were at all times full, fair and accurate" and that the company "intends to vigorously defend itself as this litigation proceeds."
Read More
